Retracted: TW‐37, a small‐molecule inhibitor of Bcl‐2, inhibits cell growth and invasion in pancreatic cancer

This article has been retracted at the request of: Editor‐in‐Chief and Author

[1]  Zhiwei Wang,et al.  Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. , 2007, Cancer research.

[2]  Douglas B. Evans,et al.  NF-κB in pancreatic cancer , 2003 .

[3]  Bonnie F. Sloane,et al.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. , 2005, The American journal of pathology.

[4]  L. Kirshenbaum,et al.  IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes. , 2002, The Journal of biological chemistry.

[5]  L. Kirshenbaum,et al.  Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. , 1998, The Journal of biological chemistry.

[6]  Shaomeng Wang,et al.  Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. , 2005, Cancer research.

[7]  S. Curran,et al.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. , 2000, European journal of cancer.

[8]  E. Giovannetti,et al.  Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer , 2006, Molecular Cancer Therapeutics.

[9]  James T. Elder,et al.  A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. , 2006, Cancer research.

[10]  B. Aggarwal,et al.  Evodiamine Abolishes Constitutive and Inducible NF-κB Activation by Inhibiting IκBα Kinase Activation, Thereby Suppressing NF-κB-regulated Antiapoptotic and Metastatic Gene Expression, Up-regulating Apoptosis, and Inhibiting Invasion* , 2005, Journal of Biological Chemistry.

[11]  T. Gilmore.  Multiple Myeloma: Lusting for NF-κB , 2007 .

[12]  B. Aggarwal,et al.  Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. , 2005, The Journal of biological chemistry.

[13]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[14]  A. Ricca,et al.  bcl‐2 over‐expression enhances NF‐κB activity and induces mmp‐9 transcription in human MCF7ADR breast‐cancer cells , 2000, International journal of cancer.

[15]  C P Neal,et al.  Molecular prognostic markers in pancreatic cancer: a systematic review. , 2005, European journal of cancer.

[16]  H. Abaan,et al.  Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. , 2006, Journal of medicinal chemistry.

[17]  L. Kirshenbaum,et al.  IKKβ Is Required for Bcl-2-mediated NF-κB Activation in Ventricular Myocytes* , 2002, The Journal of Biological Chemistry.

[18]  C. Waes.  Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer , 2007 .

[19]  L. Kirshenbaum,et al.  Bcl-2 Activates the Transcription Factor NFκB through the Degradation of the Cytoplasmic Inhibitor IκBα* , 1998, The Journal of Biological Chemistry.

[20]  F. Sarkar,et al.  Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents. , 1998, Pancreas.

[21]  D. Andrews,et al.  Suppression of IP3-mediated calcium release and apoptosis by Bcl-2 involves the participation of protein phosphatase 1 , 2006, Molecular and Cellular Biochemistry.

[22]  Kyusam Choi,et al.  Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. , 2005, Cancer research.

[23]  C. Van Waes.  Nuclear factor-kappaB in development, prevention, and therapy of cancer. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  Zhiwei Wang,et al.  Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. , 2006, Cancer research.

[25]  Zhiwei Wang,et al.  Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. , 2006, Cancer research.

[26]  Y. Nagakawa,et al.  Histologic Features of Venous Invasion, Expression of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9, and the Relation with Liver Metastasis in Pancreatic Cancer , 2002, Pancreas.

[27]  Sanjeev Banerjee,et al.  Preclinical Studies of TW-37, a New Nonpeptidic Small-Molecule Inhibitor of Bcl-2, in Diffuse Large Cell Lymphoma Xenograft Model Reveal Drug Action on Both Bcl-2 and Mcl-1 , 2007, Clinical Cancer Research.

[28]  Sanjeev Banerjee,et al.  Nonpeptidic Small-Molecule Inhibitor of Bcl-2 and Bcl-XL, (−)-Gossypol, Enhances Biological Effect of Genistein Against BxPC-3 Human Pancreatic Cancer Cell Line , 2005, Pancreas.

[29]  H. Kung,et al.  BCL‐2 functions as an activator of the AKT signaling pathway in pancreatic cancer , 2007, Journal of cellular biochemistry.

[30]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[31]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[32]  B. Aggarwal,et al.  Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation , 2004, Oncogene.

[33]  Douglas B. Evans,et al.  NF-kappaB in pancreatic cancer. , 2003, International journal of gastrointestinal cancer.

[34]  T. Gilmore.  Multiple myeloma: lusting for NF-kappaB. , 2007, Cancer cell.

[35]  H. Um,et al.  Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. , 2006, Cancer research.

[36]  Sanjeev Banerjee,et al.  Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts , 2006, Cancer.

[37]  F. Roviello,et al.  Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer , 2006, Breast Cancer Research and Treatment.

[38]  Shaomeng Wang,et al.  Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2. , 2006, Cancer research.